Diabetes (type 2) Clinical Trial

KRK Medical Research is seeking volunteers to participate in one of five clinical research study to evaluate the effectiveness of an investigational medication for treatment of Diabetes (type2).

This is a national study sponsored by GlaxoSmithKline. Our study site is located in Dallas, Texas.

In order to qualify you must meet the following criteria:
• Age 18 and older
• Type 2 Diabetes

Participation Duration: This study will last up to 52 weeks and may require up to 26 visits. There is also a 52 week optional study period for those who choose to remain on the medication.

All study related medical procedures, physical examinations, physician visits, laboratory tests and investigational medication are at no charge. No health insurance is needed.

You will also receive compensation up to $1500 for your time and travel.

Please email us below if you would like to receive more information about this study. We will contact you by phone or e-mail within 24 hours. Be assured that all information is kept strictly confidential per HIPAA regulations, FDA laws and the American Medical Association ethical guidelines.


If you would like to receive more information about the Diabetes (type 2) Clinical Trial, please Click Here and email your name and phone number to receive a response from one of our Nurse Research Coordinators.

You may also call one of our patient specialists at 972-907-1333.